Home > Financial Ratios > PIRAMAL PHARMA

PIRAMAL PHARMA
EV/Core EBITDA

    Back to All Ratios
AD     Remove this Ad

PIRAMAL PHARMA Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/Core EBITDA(x) 21.4915.4015.663.982.20

What is the latest EV/Core EBITDA ratio of PIRAMAL PHARMA ?

The latest EV/Core EBITDA ratio of PIRAMAL PHARMA is 21.49 based on Mar2025 Consolidated results.
Year EV/Core EBITDA
Mar202521.49
Mar202415.40
Mar202315.66
Mar20223.98
Mar20212.20

How is EV/Core EBITDA of PIRAMAL PHARMA Trending?

Years EV/Core EBITDA % Change
Mar2025 21.49
39.55
Mar2024 15.4
-1.66
Mar2023 15.66
293.47
Mar2022 3.98
80.91
Mar2021 2.2 -

Other Financial Ratios of PIRAMAL PHARMA


Compare EV/Core EBITDA ratio of peers of PIRAMAL PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
PIRAMAL PHARMA ₹21,838.8 Cr 0.5% -1.2% -25% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹407,827.0 Cr -0.5% 1.8% -2% Stock Analytics
DIVIS LABORATORIES ₹163,363.0 Cr -0.3% -1.3% 4% Stock Analytics
TORRENT PHARMACEUTICALS ₹144,193.0 Cr 4.4% 6% 27.7% Stock Analytics
CIPLA ₹109,519.0 Cr 1% -3% -8.7% Stock Analytics
DR REDDYS LABORATORIES ₹105,940.0 Cr 1.1% 8% 3.8% Stock Analytics


PIRAMAL PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
PIRAMAL PHARMA

0.5%

-1.2%

-25%

SENSEX

-0.9%

-0.1%

7%


You may also like the below Video Courses